Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Big Ten Cancer Research Consortium
Big Ten Cancer Research Consortium
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Nationwide Children's Hospital
IFOM ETS - The AIRC Institute of Molecular Oncology
Roswell Park Cancer Institute
Medical University of Vienna
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
University of Florida
Mayo Clinic
University of Birmingham
Centre Hospitalier Universitaire de Besancon
NRG Oncology
M.D. Anderson Cancer Center
Augusta University
OHSU Knight Cancer Institute
University of California, San Francisco
City of Hope Medical Center
Sun Yat-sen University
St. Jude Children's Research Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ohio State University Comprehensive Cancer Center
AHS Cancer Control Alberta
University of Iowa
Abramson Cancer Center at Penn Medicine
Case Comprehensive Cancer Center
Stanford University
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
New Approaches to Neuroblastoma Therapy Consortium
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Second Affiliated Hospital, School of Medicine, Zhejiang University
Massachusetts General Hospital
Nationwide Children's Hospital
Medical College of Wisconsin
St. Jude Children's Research Hospital
Emory University
Peking University People's Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
NRG Oncology
Mayo Clinic
Washington University School of Medicine
Sun Yat-sen University
Sun Yat-sen University
The First Affiliated Hospital of Zhengzhou University
Olympion Medical Center
Duke University
Mayo Clinic